$MLAB
MESA LABORATORIES INC /CO/

2022 Q1 Form 10-Q Financial Statement

#000143774922002291 Filed on February 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q3
Revenue $58.88M $54.70M $35.84M
YoY Change 55.09% 60.06% 12.49%
Cost Of Revenue $23.77M $26.07M $12.70M
YoY Change 79.64% 92.83% 20.09%
Gross Profit $35.11M $28.63M $23.14M
YoY Change 41.95% 38.61% 8.72%
Gross Profit Margin 59.63% 52.34% 64.56%
Selling, General & Admin $30.04M $25.98M $16.33M
YoY Change 69.93% 44.9% 13.37%
% of Gross Profit 85.56% 90.74% 70.55%
Research & Development $5.179M $5.164M $2.613M
YoY Change 93.97% 90.91% 8.24%
% of Gross Profit 14.75% 18.04% 11.29%
Depreciation & Amortization $24.61M $6.837M $4.277M
YoY Change 120.13% 48.63% -3.24%
% of Gross Profit 70.08% 23.88% 18.48%
Operating Expenses $35.22M $31.14M $18.94M
YoY Change 73.08% 50.93% 12.63%
Operating Profit -$110.0K -$2.512M $4.201M
YoY Change -102.51% -11518.18% -6.02%
Interest Expense -$1.238M $1.018M $815.0K
YoY Change -41.33% -47.79% -57.86%
% of Operating Profit 19.4%
Other Income/Expense, Net $1.302M $171.0K $342.0K
YoY Change -51.96% -102.97% -116.4%
Pretax Income -$46.00K -$2.341M $4.543M
YoY Change -100.94% -59.12% 90.56%
Income Tax $1.738M -$281.0K $823.0K
% Of Pretax Income 18.12%
Net Earnings -$1.784M -$2.060M $3.720M
YoY Change -145.51% -54.65% 38.86%
Net Earnings / Revenue -3.03% -3.77% 10.38%
Basic Earnings Per Share -$0.39 $0.71
Diluted Earnings Per Share -$339.7K -$0.39 $0.70
COMMON SHARES
Basic Shares Outstanding 5.246M 5.233M 5.211M
Diluted Shares Outstanding 5.233M 5.344M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.35M $51.71M $278.3M
YoY Change -81.3% -79.62% 15.05%
Cash & Equivalents $49.35M $51.71M $278.3M
Short-Term Investments
Other Short-Term Assets $3.735M $8.281M $6.357M
YoY Change -23.78% -9.99% -18.5%
Inventory $24.61M $23.72M $12.12M
Prepaid Expenses
Receivables $41.22M $37.29M $22.64M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $124.3M $121.0M $319.4M
YoY Change -59.07% -59.02% 14.02%
LONG-TERM ASSETS
Property, Plant & Equipment $28.62M $30.15M $22.39M
YoY Change 30.1% 35.24% 0.37%
Goodwill $291.2M $293.5M $160.0M
YoY Change 81.03% 77.06% 2.31%
Intangibles $264.7M $103.5M
YoY Change 119.09% -11.32%
Long-Term Investments
YoY Change
Other Assets $11.83M $11.76M $1.979M
YoY Change 367.59% 551.33% 0.1%
Total Long-Term Assets $583.1M $600.7M $289.7M
YoY Change 95.83% 84.07% -6.19%
TOTAL ASSETS
Total Short-Term Assets $124.3M $121.0M $319.4M
Total Long-Term Assets $583.1M $600.7M $289.7M
Total Assets $707.4M $721.7M $609.1M
YoY Change 17.61% 16.1% 3.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.897M $7.827M $4.463M
YoY Change 76.55% 108.66% 140.98%
Accrued Expenses $11.61M $12.49M $8.836M
YoY Change 16.75% 36.25% 85.9%
Deferred Revenue $13.83M $12.48M $9.741M
YoY Change 57.57% 63.26% 43.46%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $48.06M $46.78M $28.69M
YoY Change 47.48% 68.56% 46.88%
LONG-TERM LIABILITIES
Long-Term Debt $218.4M $229.1M $168.9M
YoY Change 49.87% 58.79% 18.21%
Other Long-Term Liabilities $7.924M $8.334M $436.0K
YoY Change 1008.25% 1114.87% -54.2%
Total Long-Term Liabilities $7.924M $8.334M $436.0K
YoY Change 1008.25% 1114.87% -54.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $48.06M $46.78M $28.69M
Total Long-Term Liabilities $7.924M $8.334M $436.0K
Total Liabilities $313.6M $325.4M $209.7M
YoY Change 60.6% 55.8% 6.7%
SHAREHOLDERS EQUITY
Retained Earnings $76.68M $79.30M $82.20M
YoY Change 5.82% 14.33% 10.0%
Common Stock $313.5M $308.2M $302.2M
YoY Change -1.32% -2.01% -2.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $393.8M $396.3M $399.4M
YoY Change
Total Liabilities & Shareholders Equity $707.4M $721.7M $609.1M
YoY Change 17.61% 16.1% 3.42%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q3
OPERATING ACTIVITIES
Net Income -$1.784M -$2.060M $3.720M
YoY Change -145.51% -54.65% 38.86%
Depreciation, Depletion And Amortization $24.61M $6.837M $4.277M
YoY Change 120.13% 48.63% -3.24%
Cash From Operating Activities $9.302M $15.90M $4.434M
YoY Change -31.2% 45.32% -57.93%
INVESTING ACTIVITIES
Capital Expenditures -$782.0K -$2.059M -$938.0K
YoY Change -24.81% 757.92% 91.43%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$300.8M
YoY Change
Cash From Investing Activities -$782.0K -$302.9M -$938.0K
YoY Change -24.81% 126088.33% 91.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.05M 61.20M 1.158M
YoY Change 856.86% 33900.0% 451.43%
NET CHANGE
Cash From Operating Activities 9.302M 15.90M 4.434M
Cash From Investing Activities -782.0K -302.9M -938.0K
Cash From Financing Activities -10.05M 61.20M 1.158M
Net Change In Cash -1.527M -225.8M 4.654M
YoY Change -113.36% -2174.94% -54.64%
FREE CASH FLOW
Cash From Operating Activities $9.302M $15.90M $4.434M
Capital Expenditures -$782.0K -$2.059M -$938.0K
Free Cash Flow $10.08M $17.96M $5.372M
YoY Change -30.74% 60.62% -51.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5245943
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
339000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
218000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17988000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16330000 USD
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5244628
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5244628
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5140568
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5140568
CY2021Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2021Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2021Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
9315000 USD
CY2020Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2020Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
991000 USD
CY2020Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2020Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
819000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3611000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
21142000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 pure
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2021Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
6447000 USD
us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2019
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51706000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
263865000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37289000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23787000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
23719000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
11178000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8281000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4919000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
120995000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
303749000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30152000 USD
CY2021Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 USD
CY2021Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
169140000 USD
CY2021Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
145675000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
325383000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
195248000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
308208000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
317652000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
79302000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
72459000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21998000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
594000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
616000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11763000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2530000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
264666000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
111741000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
293542000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
160841000 USD
CY2021Q4 us-gaap Assets
Assets
721712000 USD
CY2021Q1 us-gaap Assets
Assets
601475000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7827000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4473000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13978000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9388000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
12483000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8777000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12487000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9945000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
46775000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
32583000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
41134000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
16275000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8334000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
715000 USD
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
60000000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8819000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
16116000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
396329000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
406227000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
721712000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
601475000 USD
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
26069000 USD
CY2020Q4 us-gaap Cost Of Revenue
CostOfRevenue
13519000 USD
us-gaap Cost Of Revenue
CostOfRevenue
51478000 USD
us-gaap Cost Of Revenue
CostOfRevenue
33695000 USD
CY2021Q4 us-gaap Gross Profit
GrossProfit
28627000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
20653000 USD
us-gaap Gross Profit
GrossProfit
73978000 USD
us-gaap Gross Profit
GrossProfit
62278000 USD
CY2021Q4 us-gaap Selling Expense
SellingExpense
8958000 USD
CY2020Q4 us-gaap Selling Expense
SellingExpense
4753000 USD
us-gaap Selling Expense
SellingExpense
18459000 USD
us-gaap Selling Expense
SellingExpense
12614000 USD
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17017000 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13173000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40119000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33887000 USD
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5164000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2705000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10588000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7715000 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
31139000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
20631000 USD
us-gaap Operating Expenses
OperatingExpenses
69166000 USD
us-gaap Operating Expenses
OperatingExpenses
54216000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2512000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
22000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4812000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
8062000 USD
CY2021Q4 us-gaap Interest Expense
InterestExpense
1018000 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
1950000 USD
us-gaap Interest Expense
InterestExpense
2647000 USD
us-gaap Interest Expense
InterestExpense
5803000 USD
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1189000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3799000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1455000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4848000 USD
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
171000 USD
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5749000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1192000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10651000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2341000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5727000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3620000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2589000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-281000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1185000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-35000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1943000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2060000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-4542000 USD
us-gaap Net Income Loss
NetIncomeLoss
3655000 USD
us-gaap Net Income Loss
NetIncomeLoss
-646000 USD
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5233000
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5125000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5199000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4922000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5233000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5125000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5333000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4922000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2060000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-4542000 USD
us-gaap Net Income Loss
NetIncomeLoss
3655000 USD
us-gaap Net Income Loss
NetIncomeLoss
-646000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6165000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
21142000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7297000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
39264000 USD
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8225000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16600000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3642000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
38618000 USD
us-gaap Net Income Loss
NetIncomeLoss
3655000 USD
us-gaap Net Income Loss
NetIncomeLoss
-646000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15686000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12933000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7939000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6887000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
804000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
4024000 USD
mlab Amortization Of Inventory Stepup Cost
AmortizationOfInventoryStepupCost
6062000 USD
mlab Amortization Of Inventory Stepup Cost
AmortizationOfInventoryStepupCost
-436000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1375000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4583000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-67000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
917000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2258000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2224000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-351000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
485000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1933000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2691000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1270000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
71000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1403000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2517000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1056000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
523000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29921000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23553000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
300793000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
-0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3650000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
954000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-304443000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-954000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
70000000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
10000000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
-0 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
2495000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
2341000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5352000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3692000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
234000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
11000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
145935000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
62623000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
147275000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-260000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2477000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-212159000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
172351000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
263865000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
81380000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
51706000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
253731000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
406227000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1089000 USD
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
824000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2197000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5371000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1995000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
399003000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1992000 USD
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
834000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2039000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6503000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3720000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
399417000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2271000 USD
CY2021Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
837000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3703000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6165000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2060000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
396329000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
220013000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
145935000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1654000 USD
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
704000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1268000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12860000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1217000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
382234000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1047000 USD
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
818000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2008000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5262000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2679000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
392412000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-4542000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
412795000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
54696000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34172000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
125456000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
95973000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
54696000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34172000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
125456000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
95973000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8994000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5387000 USD
mlab Contract With Customer Liability Increase During Period Net Of Revenue Recognized
ContractWithCustomerLiabilityIncreaseDuringPeriodNetOfRevenueRecognized
10201000 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13808000 USD
CY2021Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
0 USD
CY2021Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
230822000 USD
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
13962000 USD
CY2021Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
5755000 USD
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1956000 USD
CY2021Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
426000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7801000 USD
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4997000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
23719000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
11178000 USD
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
6289000 USD
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
6397000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2733000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1023000 USD
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
918000 USD
CY2021Q1 us-gaap Interest Payable Current
InterestPayableCurrent
303000 USD
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
606000 USD
CY2021Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
253000 USD
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
547000 USD
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
473000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1394000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1496000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12487000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9945000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
342255000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
77589000 USD
CY2021Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5922000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13495000 USD
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3828000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
264666000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
176866000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
65125000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
111741000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10694000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
25670000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
25154000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
23566000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
22789000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
160841000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-3305000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
136006000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
293542000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3703000 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3611000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7939000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6887000 USD
CY2021Q4 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-743000 USD
CY2020Q4 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
320000 USD
mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-4247000 USD
mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-1127000 USD
CY2021Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2960000 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
3931000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
3692000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
5760000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
253000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
129.55
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y8M12D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
28856000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
37000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
268.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
4000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
191.52
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
62000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
98.99
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
224000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
159.79
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y9M18D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
37597000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2060000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-4542000 USD
us-gaap Net Income Loss
NetIncomeLoss
3655000 USD
us-gaap Net Income Loss
NetIncomeLoss
-646000 USD
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5233000
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5125000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5199000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4922000
CY2021Q4 mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
0
CY2020Q4 mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
0
mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
107000
mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
0
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5233000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5125000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5333000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4922000
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
933000
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
926000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
664000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
938000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.010 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.75 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q4 us-gaap Gross Profit
GrossProfit
28627000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
20653000 USD
us-gaap Gross Profit
GrossProfit
73978000 USD
us-gaap Gross Profit
GrossProfit
62278000 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
31139000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
20631000 USD
us-gaap Operating Expenses
OperatingExpenses
69166000 USD
us-gaap Operating Expenses
OperatingExpenses
54216000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2512000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
22000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4812000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
8062000 USD
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
171000 USD
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5749000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1192000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10651000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2341000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5727000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3620000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2589000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
23719000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
11178000 USD

Files In Submission

Name View Source Status
0001437749-22-002291-index-headers.html Edgar Link pending
0001437749-22-002291-index.html Edgar Link pending
0001437749-22-002291.txt Edgar Link pending
0001437749-22-002291-xbrl.zip Edgar Link pending
ex_310820.htm Edgar Link pending
ex_310821.htm Edgar Link pending
ex_310822.htm Edgar Link pending
ex_310823.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mlab-20211231.xsd Edgar Link pending
mlab-20211231_cal.xml Edgar Link unprocessable
mlab-20211231_def.xml Edgar Link unprocessable
mlab-20211231_lab.xml Edgar Link unprocessable
mlab-20211231_pre.xml Edgar Link unprocessable
mlab20211231_10q.htm Edgar Link pending
mlab20211231_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending